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Theexponential useofrobotic surgery isnottheresult ofevidence-based beneﬁts but mainlydriven bythemanufacturers, patients
and enthusiastic surgeons. The present review of the literature shows that robot-assisted surgery is consistently more expensive
than video-laparoscopy and in many cases open surgery. The average additional variable cost for gynecological procedures was
about 1600USD, rising to more than 3000USD when the amortized cost of the robot itself was included. Generally most robotic
and laparoscopic procedures have less short-term morbidity, blood loss, intensive care unit, and hospital stay than open surgery.
Up to now no majorconsistent diﬀerences have been found between robot-assisted and classic video-assisted procedures for these
factors. No comparative data are available on long-term morbidity and oncologic outcome after open, robotic, and laparoscopic
gynecologic surgery. It seemsthat currently onlyforvery complex surgical procedures, such ascardiac surgery, thecostsofrobotics
can be competitive to open surgical procedures. In order to stay viable, robotic programs will need to pay for themselves on a per
case basis and the costs of robotic surgery will have to be reduced.
1.Introduction
The use of robotic assisted surgery has grown exponentially
over the last few years as there is a clear trend in sur-
gery, driven by patient demand, to develop less invasive
approaches to common procedures [1–7]. Robotic technol-
ogyhasgainedpopularityinvarioussurgicalspecialitiessuch
as urology, gynecology, thoracic surgery, general surgery,
and currently head and neck surgery. The Da Vinci Surgical
systemistheonlyFDA-approvedroboticsystemcurrentlyon
the market [2, 6, 8]. Robot-assisted and laparoscopic surgery
eliminates the need for large morbid and less esthetical inci-
sions and often decreases blood loss, postoperative pain, use
ofpain medication, and lengthof hospital stay [2, 6]. Advan-
tages of robotic surgery compared to laparoscopy and open
surgeryareimproveddexterity,moreprecisemovementsand
tremor reduction, and better visualization of the operating
ﬁeld (magniﬁcation and 3D).In addition, the robot ﬁngertip
hand control mechanism is “intuitive,” meaning that the ro-
botic instruments will move just as your hands move, rather
than as a mirror image movement as in laparoscopy [8]. The
robotic digital process allows scaling down the surgeons’s
hand movements to a level at which microvascular or micro-
scopic procedures are feasible. Diﬃcult, minimal invasive
surgery is accessible for surgeons without advanced laparo-
scopic training as it has a short learning curve [6, 9]. Fatigue
and frustration become less of a limiting factor for the
robotic surgeon compared to the laparoscopic surgeon [10].
The major drawback of the Da Vinci system is the loss
of tactile and force feedback. This can be surmounted by
training and is partially compensated for by the 3D visual
feedback. However, it often leads to rupturing of suture
material during knot tying by beginning robotic surgeons.
In addition placing the trocars is limited in order to avoid
collision of the robotic arms. With the current equipment,
this makes it more diﬃcult to operate in the lower and upper
abdomen simultaneously [8]. With laparoscopic surgery, the
surgeon tends to place the ports in more “natural” and ana-
tomical positions. Esthetically, ports of a laparoscopy are
much better located (e.g., the umbilicus and just medial of2 Obstetrics and Gynecology International
theanteriorsuperioriliacspine)thantheforcedtrocarplace-
ments in an arch, commonly used for robotic procedures.
The use of larger trocars (11mm versus 5mm) is an addi-
tional esthetical disadvantage for robotic surgery compared
to laparoscopy. The cart with the robotic arms, which is
positioned close to the patient, makes access to the patient
limited. Particularly in gynecologic surgery it is sometimes
diﬃcult to remove the uterus and other specimens from the
vaginaaftertherobothasbeendocked[2].Duetothesophis-
ticated technology a robotic team of specialized surgeons,
anaesthetists, and dedicated nursing staﬀ is mandatory to
make a robotic program function optimally. Particularly,
the surgeon and nursing staﬀ need speciﬁc training. This
makesthe use ofrobotic surgery lesspracticalfornonelective
cases. Conventional open surgery, laparoscopic surgery, and
robotic surgery require diﬀerent skills. Asthe robot isa high-
tech complicated instrument to master, adequate training
is mandatory before embarking on surgery in patients. It
is important to train basic laparoscopic and robotic skills
in a box trainer, on a cadaver or on animals [6]. However,
the major disadvantage of robotic surgery are the high cost
of purchase, maintenance, and instruments of the robotic





between open, laparoscopic, and robotic surgery resulting
from added expense of specialized equipment. Equipment
costs associated with laparoscopic surgery have a relatively
low per-case cost as it is multipurpose (e.g., monitors and
cameras can be used for laparoscopy but also for hys-
teroscopy) and can be used by diﬀerent specialities for many
types of surgery [11]. On the contrary, the Da Vinci robot,
costing over 1.500.000 Euro and requiring a yearly service
contract of 150.000 Euro, has a more limited number of
applications. The ﬁxed costs depend greatly upon the num-
ber of cases being operated over the amortized life span
of the robotic system. We calculated for our unit costs of
the hardware (without taking into account disposables) per
patient are 3920 Euro, 1960 Euro, 1306 Euro, and 980 Euro if
100, 200, 300, and 400 respectively, robotic proceduresa year
are performed (amortisation over7 years). Suchcostsare not
reimbursed by the hospital. The robot also oﬀers a distinct
ﬁnancial disadvantage because each instrument only has a
limited preprogrammed (n = 10) number of uses, such that
the added cost for instruments and drapings can be as high
as 1700 Euro per case. A major factor aﬀecting the costs of
laparoscopicsurgery isthepriceoflaparoscopicinstruments.
This depends on the type and number of instruments which
are used. Generally (semi) reusable instruments are cheaper
per case compared to disposable instruments [12]. Although
one would expect laparoscopic equipment costs to decrease
with time (analogous to the retail computer market), there
has been an increase in costs that exceeds inﬂation despite
an increase in the number of procedures performed in most
countries [11, 12]. There has been no decrease in the costs
of robot-related products due to the lack of market com-
petition.
2.2. Operative Times. Operativetimes playan important role
in determining the operative costs. They include the time
to start up the procedure, to do the surgery, and to prepare
the surgical theatre for the next operation. These costs are
calculated in 15–30min intervals. Costs of anesthesia also
increase over similar time intervals. In general, the setup and
breakdown of the robotic system take signiﬁcantly longer
comparedtothepreparationoflaparoscopicoropensurgery.
For many procedures, operative time is lower for open
surgery, intermediate for robotic surgery, and slightly longer
for comparable laparoscopic surgery [10]. As experience
grows with a certain techniques, operative time becomes
shorter until they stabilize at a certain level. Lenihan et al.
showed that the total operative times for robotic hysterec-
tomies stabilized at approximately 95 minutes after 50 cases
[9]. A study that evaluated the learning curve in a series
of robot-assisted laparoscopic prostatectomies found that
the learning curve may range from a low of 13 cases to
a high of 200 cases depending on the surgeon [13]. The
average initial time to perform this procedure in this cohort
was 424min, with a ﬁnal operative time of 230min per
case. The costs of the learning curve are high and can vary
widely. For robot-assisted laparoscopic prostatectomies costs
of the initial learning cure varied from 49,613 US dollars to
554,694 US dollars with an average of 217,034 US dollars
[13, 14] .A si nm o s tc e n t e r ss u r g e o n sa l r e a d yw e n tt h r o u g h
their learning curves for open and/or laparoscopic surgery
the robotic learning curve is an added cost. Operative time
in academic institutions, where residents and fellows are
trained, may be longer than in private units where the whole
surgical team is the same. To overcome these extra costs, the
concept of high volume centers is of great importance. In
such units the learning curve can be rapidly traversed and
costs minimized. Robotic surgery is speciﬁcally suitable for
virtual reality training, as the operation itself is computer
guided. Diﬀerent companies are developing virtual reality
simulators for robotic surgery. This may reduce the learning
curve signiﬁcantly and is likely to be the training of choice
for the surgeons of tomorrow [15].
2.3. Hospital Stay. Room and board costs represent an
important part of the overall cost of hospitalization. For
many procedures, the main ﬁnancial advantage for the
laparoscopic and robotic approach is the decreased hospital
staycomparedtoopensurgery[11,16].Thereducednumber
of inpatient hospital days and earlier return to diet allow
for cost savings. These savings can compensate for added
expenses in the operating room and result in cost superiority
of some procedures. It is important to realize that the costs
of hospital beds vary among hospitals, especially between
community hospitals and academic medical centers [6]. In
additioncostsofhospitalstaycanvaryfromnationtonation,
depending on the health system and the reimbursement by
insurances. Although some studies suggest that hospital stayObstetrics and Gynecology International 3
is shorter after robotic surgery compared to laparoscopy [17,
18], for most procedures there was no advantage of a robot-
assisted laparoscopic approach over a “pure” laparoscopic
approach in terms of rooms and board [19].
2.4. Other Costs. In general laparoscopic and robotic pro-
cedures allow patients to resume their normal family and
professionalactivitiessooner[8,10].Itisdiﬃculttocalculate
the savings for society as sick leave, insurance for inability
to work, and so forth vary enormously on an individual
basis. There is no evidence that long-term morbidity varies
considerably among open, laparoscopic, and robot-assisted
procedures [16].
An interesting advantage of robotic surgery is the more
ergonomic position of the surgeon to perform a procedure.
Loss of economic productivity of surgeons related to doing
laparoscopic and open surgery (e.g., cervical hernia) is a
severely underestimated factor. A survey by Matern and
Koneczny on this subject shows that 97% of surgeons
think improvement of ergonomics in the operating theatre
is necessary [20]. In a recent study Tchartchian et al.
could demonstrate that robotics improves image stability
with fewer corrective maneuvers compared to laparoscopy.
Surgeonsrecordedasigniﬁcantly highersatisfaction scorefor
the ergonomics of the robot (P<0.001) [21].
2.5. Cost Analysis of Robotic Gynecologic Procedures. Sarlos
et al. compared the costs of 40 consecutive robot-assisted
hysterectomies with 40 matched total laparoscopic hysterec-
tomies. There were no conversions to laparotomy or major
morbidity in both groups [22]. Operating time was 83 (55–
165) versus 109 (50–170) minutes and hospital stay 3.3 (2–
6) versus 3.9 (2–7) days. Average surgical costs were 4067
Euros for the robotic group compared to 2151 Euros in the
laparoscopic group.
Using the Premier Hospital Database Pasic et al. identi-
ﬁed women above 18 years of age with a record of minimally
invasive hysterectomy performed in 2007 to 2008 [23]. Of
361888 patient records analyzed from 358 hospitals, 95%
(N = 34527) of laparoscopic hysterectomies were performed
without robotic assistance [20]. Inpatient procedures with
andwithoutroboticscost9640versus6973USD,respectively
(diﬀerence strongly signiﬁcant). Similar diﬀerences were
found for outpatient procedures (7920 versus 5949 USD).
There were little clinical diﬀerences in perioperative and
postoperative events. Only surgical times were signiﬁcantly
longer for robot-assisted procedures.
Barnett et al. used decision modeling to compare costs
associatedwithrobotic,laparoscopic,andopenhysterectomy
[24]. The societal perspective model predicted laparoscopy
(10128 USD) as the least expensive approach followed by
robotic (11476 USD) and open hysterectomy (12847 USD).
In the hospital perspective models laparoscopy was the least
expensive (6581 USD) followed by open (7009 USD) and
robotic hysterectomy (8770 USD).
Rodgers et al., making a comparison with open surgery,
calculated that robotic surgery increased the costs for tubal
anastomosis by 1446 US dollars [25]. However Dharia
Patel et al. found that the cost per delivery was equal [26].
Robotic rectopexy proved to be 755 USD more expensive
than laparoscopic rectopexy [27]. Advincula et al. showed
thatroboticmyomectomyhadlesscomplicationsandshorter
hospital stay [28]. They calculated that mean hospital re-
imbursement was 30.064 USD (SD: 6689) for the robotic
procedure versus 13.400 USD (SD: 7720) for open surgery.
Outcomes and costs for endometrial cancer staging via
traditional laparotomy(N = 40),standard laparoscopy(N =
30), and robot-assisted surgery (N = 40) were compared in
one single institution by Bell et al. [29]. Patients undergoing
robot-assisted hysterectomy and staging experienced longer
operative times than the laparotomy cohort but with no
diﬀerenceincomparisontothelaparoscopiccohort(184min
versus 108min versus 171min, P>0.0001, P = 0.14).
Estimated blood loss was signiﬁcantly reduced for the
robotic cohort in comparison to the laparotomy cohort and
comparable to the laparoscopic cohort. The complication
rate was the lowest in the robotic group (7.5%) compared
to laparotomy (27.5%) and laparoscopic groups (20%) (P =
0.015, P = 0.03). Average return to normal activity for
the robotic patients was signiﬁcantly shorter than those
undergoing laparotomy (24 versus 52 days, P<0.001) and
those undergoing laparoscopy (31 days, P = 0.005). Lymph
node yields were similar in all groups. The total average cost
for hysterectomy with staging completed via laparotomy was
12943 USD, for standard laparoscopy 7569 USD, and for
robotic assistance 8212 USD.
2.6. How Important Are Costs? Technologic innovation in
health care is an important driver of cost growth. Doctors
and patients often embrace new modes of treatment before
their merits and weaknesses are fully understood [30].
Robotic technology has been readily adopted over the last
ﬁve years in both Europe and the United States [30–40].
The number ofrobot-assisted proceduresthat are performed
worldwide has nearly tripled since 2007, from 80000 to
250000 in 2009 [40]. The present review of the literature
shows that currently robot-assisted surgery is consistently
more expensive than video-laparoscopy and in many cases
than open surgery (Table 1). Across the full range of 20
typesofsurgeryforwhich studiesexist theaverageadditional
variable cost was about 1600 USD, rising to more than
3000 USD when the amortized cost of the robot itself was
included. It seems that currently only for very complex
surgical procedures, such as cardiac surgery, its costs can be
competitive to similar open surgical procedures [41].
It has been suggested that robotic technology may have
contributed to the substitution of surgical for nonsurgical
treatment for certain diseases [40]. The observed pattern
matches evidence from the Surveillance, Epidemiology and
End Results Medicare database which shows that Medicare
beneﬁciaries who received a diagnosis of prostate cancer in
2005 were about 14% more likely to have undergone surgery
by 2007 than their counterparts whose prostate cancer was
diagnosed 3 years earlier [41]. This will probably aﬀect costs
on the long run as some studies show that more adju-
vant radiotherapy is used after robotic prostatectomy [38].4 Obstetrics and Gynecology International
Table 1: Cost analysis of gynecologic surgical procedures per-
formed by robot-assisted laparoscopy (RAL), classic video-laparo-
scopy (CVL), and open surgery (OS). Total hospital costs are given
unless speciﬁed diﬀerently.
Author [reference] Procedure RAL CVL OS
United States
Pasic et al. [23]H y s t e r e c t o m y
Inpatient 9640$ 6973$
Outpatient 7920$ 5949$
B a r n e t te ta l .[ 24]H y s t e r e c t o m y
Social
perspective 11476$ 10128$ 12487$
Hospital
perspective 8770$ 6581$ 7009$
Advincula et al.
[28] Myomectomy 30064$ 13400$
Rodgers et al. [25] Tubal
anastomosis
Hospital costs +1446$






Bell et al. [29] Endometrial
cancer staging
(hyst+BSO+LN) 8212$ 7569$ 12943$
Europe
Sarlos et al. [22] Hysterectomy 4067C 2151C
Heemskerk et al.
[27] Rectopexy 4910$ 4165$




(hyst+BSO+LN) 6707C 4480C 4919C
hyst+BSO+LN: hysterectomy with bilateral salpingo-oophorectomy and
pelvic lymphadenectomy.
Barbash and Glied calculated that, if robot-assisted surgery
would replace conventional surgeries for the full range of
procedures for which cost studies have been done, it would
generate nearly 2.5 billion in additional health care costs in
the United States [40].
The development of new technology and new medica-
tions often has a ﬁnancial motive and the willingness of
hospitals and healthcare systems to acquire these advance-
ments often has economic consideration [16]. Hospitals
and purchasers of the machines hope of a nice return on
investment. Patients only demand the robot because the Da
Vinci surgical system is actively marketed to them as “the
most eﬀective, least invasive treatment option” [42]. The
health care system in many countries is prepared to cover
new technologies at higher rates than older technologies,
even when there is no proof that the newer technologies
providean additional beneﬁt.Therefore, thecrucialquestion
is whether robotic surgery, being more expensive, is better
than comparable traditional videoendoscopic and open
surgery.Generally,mostroboticandlaparoscopicprocedures
have less short-term morbidity, blood loss, intensive care
unit, and hospital stay than open surgery [6, 11, 22–39].
Up to now no major diﬀerences have been found between
robot-assisted and classic video-assisted procedures for these
factors in gynecologic procedures [19]. Single exception
may be surgical staging of endometrial cancer where it is a
consistent ﬁnding across all publications that robot-assisted
surgery showed less blood loss than laparoscopy. However
this diﬀerence seems not clinically relevant since it did not
have any impact on blood transfusion rate [43].
Most experienceoncostcalculationforroboticshas been
gathered in urology. In a recent editorial in European Urol-
ogy Graefen writes “Are these extra costs justiﬁed? Maybe
yes, if an advantage for robotic assisted radicalprostatectomy
overotherapproachesweredocumented,butthisiscurrently
not the case” [44]. Reviewing the literature on this subject
thisauthorconcludesthatitisclearthathighsurgicalvolume
is crucial to have a good results, but functional outcome
(i.e., continence and erectile function) is not better and
in fact signiﬁcantly more salvage radiotherapy is necessary
after robotic surgery [44]. Currently, long-term oncologic
outcome is not certain after robot-assisted prostatectomy.
Similar echos are coming from the other side of the Atlantic
[11]. The exponential use of robotic surgery is not based
onevidence-based beneﬁtsbutmainly patientdriven, stimu-
latedbyenthusiasticsurgeonswholovethese“hightechtoys”
andasmart marketing machine createdbythemanufactures.
In order to stay viable, robotic programs will need to pay for
themselves on a per-case basis. The advantages of robotics
should not be taken for granted and should be further
investigated. Multicenter international trials including a
health economic section are needed to demonstrate that the
higher costs are warranted by superior outcomes. Until then
physicians have a responsibility to society and their patients
to deliver the best possible care at justiﬁable cost.
3.FuturePerspectives
It is crucial for the future of robotics to evaluate the impli-
cation of the costs associated with robotic surgery and to
analyze what can be done to reduce redundancy and unwar-
rantedcosts.Centralisation,specialized roboticsurgeonsand
units, better OR eﬃciencies, more cases and more competi-
tion seem to be the answer. Attempts should be made by the
surgeon to minimize the costs ofrobotic surgery by reducing
the number of instruments used (4 instead of 5 instruments:
use of only one needle driver saves 292 Euro), reducing the
operating time of a procedure (by getting more experience),
training dedicated robotic surgeons (not everybody can
and should do this surgery in a unit), and stimulating
early discharge of the patient when possible (savings will
be greater in high cost university hospital versus low cost
hospital). The hospital can decrease the costs by increasing
the case load by stimulating multidisciplinary use of the
robot and centralization of robotic surgery. The annual
number of robotic operations should be as high as possible,
probably at least 300 procedures. Robotic surgery should
preferentially be used for complex surgery. Last but not least,Obstetrics and Gynecology International 5
it is of paramount importance that the price of the robot,
the maintenance costs, and the price of the drapings and
instruments are reduced by the manufacturer in order
to keep robotics aﬀordable in most health care systems.
Intuitivesurgical virtually has a monopoly in robotic surgery
and competition is needed in this ﬁeld. Manufacturers of
laparoscopic devices should be creative to make laparoscopic
surgery more accessible and to facilitate the use of video-
endoscopic surgery, which up to now seems to have a similar
eﬃcacy as robotic surgery. However, the future of robotics
looks bright as robots will become even smaller and easier to
handle, surgeons will get better performing robotic surgery,
and eventually robots will become cheaper as almost all
electronic devices did when they became more mature with
many competitors on the market.
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